API logo

Cost Effective API Scale – Up from Lab to Plant

VENUE: HOTEL KOHINOOR CONTINENTAL, MUMBAI

Overview

api-industry

We are delighted to announce the Inaugural Edition of Pharma API Leaders Conclave which is going to held in Mumbai during 19th & 20th January 2023. The Conclave provides a meaningful theme “Cost Effective API Scale – Up from Lab to Plant” & will assemble leading specialist from around the world.

The Indian API industry is the most extensive and complex manufacturing sector. Its size, complexity, and diversity of products are hard to comprehend. It has an annual turnover of over 2 trillion U.S. dollars, has over 58,000 manufacturers, and generates employment for close to two million people directly and indirectly. The Indian pharmaceutical industry is growing steadily in the field of various therapies.

In FY22, the sector recorded a 7-9 percent growth, mainly driven by market access to developing nations and emerging economies like India. The key drivers of revenue growth expected over the forecast period include:

  • Increasing the share of value-added services for the treatments.
  • Growing FDI inflows.
  • Enhancing efficiency in production processes.
  • Digitalization and technological advancements.

We hope to meet you at Pharma API Leaders Conclave 2023, which will not only open doors to your profession, but also future opportunities, new cultures, & global perspectives.

Key Discussion Points

  • Current Global Trends & Status of Indian API Industry.
  • The Future of HPAPIs, Cost/Risk Analysis & Advanced Manufacturing Challenges
  • Impurities in Drug Substances / Products – Current Global Guidance (Nitrosamines & Other impurities)
  • GMP Inspection Relevance for API Manufacturing Sterile API Current Global Scenario
  • Regulatory Updates & Challenges for API Industry
  • Efficient Development, Scale up, & Tech transfer of API up to Commercial scale
  • Reshaping the Pharmaceutical API Industry with Digital Transformation
  • Particle Size of API on Formulation Success
  • Continuous Crystallisation of Active Pharmaceutical Ingredients
  • ESG Trends & Practices

Highlights

Keynote Address

Extensive B2B Meetings

10+ EXHIBITORS

Leadership Talk

30+ Plenary Speakers

Sponsors Presentation

4 Panel Discussion

Case Studies

150+ Decision Makers

Who Should Attend

Manufacturing & Tech Transfer

Production, Process Engineering, Flow Chemistry

Research and development

Quality Regulatory

CEO & Head of the above Departments

Others

Who Should Sponsor

  • Partner with the largest and longest standing highly potent meeting to position your organization as a reliable thought leading solution provider in this increasingly competitive landscape
  • We unite those with the buying power including heads of CMC and outsourcing, with the scientists and engineers on the ground scouting the best equipment and services to advance their API / HPAPI pipeline.
  • With pharma pipelines continuing to increase in potency, and the production hazards of new modalities are coming the light, API/ HPAPI continues to be a core priority for large pharma and biotech alike. However, they are searching for support in many of the following areas:
  • CMO/CDMO with reliable HPAPI capabilities
  • Technology & PAT Software Companies
  • Flow Chemistry Equipment providers
  • Analytical Companies
  • Innovative containment solutions that help with flexible API / HPAPI development and manufacturing
  • Cleanroom solutions and environmental monitoring solutions to reflect to reflect GMP compliance and EHS requirements
  • Consulting services

Register Now

7718843607

marketing@bluetech-media.com